StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

CASI Pharmaceuticals's enterprise value was $15.62M on Oct 19, 2026, against $27.23M a year earlier. Over the last 5 years it ranged from -$23.55M to $99.41M, with a median of $20.72M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$15.62M-13.7%
2025Dec 31, 2025$18.09M-34.6%
2024Dec 31, 2024$27.66M-42.1%
2023Dec 29, 2023$47.78M–
2022Dec 30, 2022-$23.55M-126.7%
2021Dec 31, 2021$88.36M–

More CASI Pharmaceuticals figures

See a number that looks wrong?